Article: Pozen Reports Positive Results In First Phase III Trial Of MT 300.

Article: POZEN STARTS PHASE III OF MT 300, PLANS TO ...
BIOWORLD Today;  February 4, 2002 ;     700+ words ... ... Pozen Inc. began the final Phase III pivotal trial of MT 300 for treatment of severe ... N.C., now has two Phase III trials under way for MT 300, an injectable dihydroergotamine ... continuing its work on a another Phase III trial for MT 300, which involves 600 ...

Article: POZEN Inc. Completes MT 100 Phase III Trials ...
PR Newswire;  November 28, 2000 ;     700+ words ... ... two late-stage Phase III clinical trials ... product candidate, MT 100, have been ... completion of two Phase III clinical trials comparing MT 100 to its components ... clinical trial was a Phase III open-label ... safety study for MT 100 initiated in ...

Article: Pozen's Second Phase III Confirms MT 100 On ...
BIOWORLD Today;  November 4, 2009 ;     700+ words ... ... Inc. completed a second Phase III trial demonstrating that MT 100, its lead product candidate ... trial, actually the sixth Phase III trial for MT 100, included 1,027 migraine ... migraine. It began the final Phase III trial of MT 300, an injectable ...

Article: MT 100 Phase III Trials Completed.(migraine ...
Pain & Central Nervous System Week;  December 23, 2000 ;     700+ words ... ... two late-stage Phase III clinical trials ... product candidate, MT 100, have been ... completion of two Phase III clinical trials comparing MT 100 to its components ... clinical trial was a Phase III open-label ... safety study for MT 100 initiated in ...

Article: POZEN REPORTS POSITIVE RESULTS IN FIRST PHASE III ...
BIOWORLD Today;  July 23, 2002 ;     700+ words ... ... preliminary data from a Phase III trial of MT 300 for migraine ... completed." The second Phase III trial is "similarly ... product in December. MT 300 is a semi-synthetic ... site reaction in the Phase III trial. However ... said. "We think MT 300 will offer an ...

Article: POZEN'S MT 100 Meets Primary Endpoint in Final ...
PR Newswire;  February 21, 2001 ;     700+ words ... ... announced that the final Phase III clinical trial for MT 100, the company ... satisfied all the Phase III clinical requirements ... Administration (FDA) for MT 100," said John ... the course of four Phase III comparative trials ... consistently shown that MT 100 provides ...

Article: POZEN Inc. Commences Final MT 300 Phase III ...
PR Newswire;  January 31, 2002 ;     700+ words ... ... second and final planned Phase III pivotal trial for approval of MT 300, the company's injectable ... to compare the efficacy of MT 300 to placebo, with sustained ... as secondary endpoints. MT 300's initial Phase III pivotal trial is expected ...